Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> Africa Eradicates Wild Poliovirus 25/08/2020 Editorial team Brazzaville – The independent Africa Regional Certification Commission (ARCC) for Polio Eradication officially declared on Tuesday that the World Health Organization (WHO) African Region is free of wild poliovirus. This marks the eradication of the second virus from the face of the continent since smallpox 40 years ago. And while vaccine derived polio is still circulating […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> One In 10 European Schools Lack Basic Hand-Washing Facilities – Adding To COVID-19 Risks As Schools Reopen 21/07/2020 Svĕt Lustig Vijay In past decades, Europe has achieved one of the world’s highest water and sanitation coverages, but it is often forgotten that one in ten schools in the 53 countries of WHO’s European region still lack basic hand washing facilities, leaving some 5 million pupils without access to soap and clean water. All in all, some 31 […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Eradicates Wild Poliovirus 25/08/2020 Editorial team Brazzaville – The independent Africa Regional Certification Commission (ARCC) for Polio Eradication officially declared on Tuesday that the World Health Organization (WHO) African Region is free of wild poliovirus. This marks the eradication of the second virus from the face of the continent since smallpox 40 years ago. And while vaccine derived polio is still circulating […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> One In 10 European Schools Lack Basic Hand-Washing Facilities – Adding To COVID-19 Risks As Schools Reopen 21/07/2020 Svĕt Lustig Vijay In past decades, Europe has achieved one of the world’s highest water and sanitation coverages, but it is often forgotten that one in ten schools in the 53 countries of WHO’s European region still lack basic hand washing facilities, leaving some 5 million pupils without access to soap and clean water. All in all, some 31 […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> One In 10 European Schools Lack Basic Hand-Washing Facilities – Adding To COVID-19 Risks As Schools Reopen 21/07/2020 Svĕt Lustig Vijay In past decades, Europe has achieved one of the world’s highest water and sanitation coverages, but it is often forgotten that one in ten schools in the 53 countries of WHO’s European region still lack basic hand washing facilities, leaving some 5 million pupils without access to soap and clean water. All in all, some 31 […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> One In 10 European Schools Lack Basic Hand-Washing Facilities – Adding To COVID-19 Risks As Schools Reopen 21/07/2020 Svĕt Lustig Vijay In past decades, Europe has achieved one of the world’s highest water and sanitation coverages, but it is often forgotten that one in ten schools in the 53 countries of WHO’s European region still lack basic hand washing facilities, leaving some 5 million pupils without access to soap and clean water. All in all, some 31 […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> One In 10 European Schools Lack Basic Hand-Washing Facilities – Adding To COVID-19 Risks As Schools Reopen 21/07/2020 Svĕt Lustig Vijay In past decades, Europe has achieved one of the world’s highest water and sanitation coverages, but it is often forgotten that one in ten schools in the 53 countries of WHO’s European region still lack basic hand washing facilities, leaving some 5 million pupils without access to soap and clean water. All in all, some 31 […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> One In 10 European Schools Lack Basic Hand-Washing Facilities – Adding To COVID-19 Risks As Schools Reopen 21/07/2020 Svĕt Lustig Vijay In past decades, Europe has achieved one of the world’s highest water and sanitation coverages, but it is often forgotten that one in ten schools in the 53 countries of WHO’s European region still lack basic hand washing facilities, leaving some 5 million pupils without access to soap and clean water. All in all, some 31 […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
One In 10 European Schools Lack Basic Hand-Washing Facilities – Adding To COVID-19 Risks As Schools Reopen 21/07/2020 Svĕt Lustig Vijay In past decades, Europe has achieved one of the world’s highest water and sanitation coverages, but it is often forgotten that one in ten schools in the 53 countries of WHO’s European region still lack basic hand washing facilities, leaving some 5 million pupils without access to soap and clean water. All in all, some 31 […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older postsNewer posts